Clinical Trials Browser

Phase 1/2 × Recurrence × cabozantinib × Clear all

NCT01866293 2017-08-30

Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Phase 1/2 Completed

11 enrolled 12 charts

Multiple Myeloma, Recurrence